William Hawkins
William Hawkins
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
William Hawkins has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Kamila Gromek
GlaxoSmithKline, Gunnels Wood Road Stevenage Herts SG1 2NY, United Kingdom
2 shared publications - Claudia Sehner
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
1 shared publication - David G. Dolan
Amgen Inc., 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA
1 shared publication - Davide Ballabio
Milano Chemometrics and QSAR Research Group, Department of Earth and Environmental Sciences, University of Milano-Bicocca, Milan, Italy
1 shared publication - Ester Lovsin Barle
Novartis Pharma AG, Novartis Business Services, Postfach, CH-4002, Basel, Switzerland; Takeda Pharmaceutical Company Limited, Thurgauerstrasse 130, CH-8152, Glattpark (Opfikon), Switzerland
1 shared publication - Eva Zeller
Boehringer Ingelheim, Germany
1 shared publication
Latest Publications
- 1 March 2022
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 129, 105109
Evaluation of the predictivity of Acute Oral Toxicity (AOT) structure-activity relationship models
- 1 March 2022
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 129, 105109
Evaluation of the predictivity of Acute Oral Toxicity (AOT) structure-activity relationship models
- 1 August 2020
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 115, 104692
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
- 1 August 2020
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 115, 104692
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2